Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review.
about
New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologistsIrritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatmentsAcupuncture for visceral pain: neural substrates and potential mechanisms.A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.The safety of novel drugs used to treat irritable bowel syndrome.Novel nervous system mechanisms in visceral pain.Inhibition of visceral nociceptors.Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome.Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug designThe κ-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons.New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide.Increased κ-opioid receptor expression and function during chronic visceral hypersensitivity.
P2860
Q26748617-3B1CE941-EF20-404D-8656-C661067DF6EFQ34660338-87D85F09-0FE9-4ABD-8FF7-720B4B3490A9Q34966570-507D62A1-1498-4A98-9D07-AA9B98102CD2Q37653402-A3BD912A-9639-4412-871E-16DCFE5C529EQ38199522-4E178BB4-9B6E-44E2-BF84-C140AE01DF4EQ38739236-8E2C7E29-9571-428B-8A73-CDF2EA894F0AQ38884350-349E648F-F99A-4FD6-83B7-CA6369C64435Q39058964-ED59B958-C197-4379-88CC-C85DDC6D6488Q39522869-266A2F79-4257-4813-99DA-F9BD550ABDD8Q42142075-897C6247-0006-434F-AB9A-FCD8DE32435CQ42695148-60CEE2BE-DC99-4618-82E5-2A1C218B8926Q43312030-405125C4-FADE-4B84-9A6B-4D7EE1FA6506Q44342283-63D61EFE-EF16-465C-9B54-FCD32B8FB920
P2860
Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Asimadoline and its potential ...... able bowel syndrome: a review.
@ast
Asimadoline and its potential ...... able bowel syndrome: a review.
@en
type
label
Asimadoline and its potential ...... able bowel syndrome: a review.
@ast
Asimadoline and its potential ...... able bowel syndrome: a review.
@en
prefLabel
Asimadoline and its potential ...... able bowel syndrome: a review.
@ast
Asimadoline and its potential ...... able bowel syndrome: a review.
@en
P2860
P356
P1476
Asimadoline and its potential ...... able bowel syndrome: a review.
@en
P2093
Allen W Mangel
Gareth A Hicks
P2860
P356
10.2147/CEG.S23274
P407
P577
2012-01-12T00:00:00Z